Enasidenib T2346
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Enasidenib is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity.
CAS nr:
1446502-11-9
Purity:
98%
Molecular Weight:
473,38
SMILES:
CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F
Formula:
C19H17F6N7O
Pathway:
Metabolism,Metabolism
Target:
Isocitrate Dehydrogenase (IDH),Dehydrogenase
